3
5M
3
0.11
1
1
- Areas of investment
Summary
In 1994 was created HC2, which is appeared as Corporate Investor. The venture was found in North America in United States. The main department of described Corporate Investor is located in the Herndon.
Deals in the range of 5 - 10 millions dollars are the general things for fund. The important activity for fund was in 2017. The fund is constantly included in less than 2 investment rounds annually. The real fund results show that this Corporate Investor is 47 percentage points more often commits exit comparing to other companies.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the HC2, startups are often financed by Pansend Life Sciences, LLC, In-Q-Tel. The meaningful sponsors for the fund in investment in the same round are Leo Capital Holdings.
We can highlight the next thriving fund investment areas, such as Search Engine, iOS. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight MediBeacon, Nervve Technologies.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 0.11
- Investments by industry
- Video (2)
- Android (1)
- Video Games (1)
- iOS (1)
- Sports (1) Show 9 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 0.33
- Avg. company exit year
- 6
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| MediBeacon | 27 Mar 2017 | Biotechnology, Health Care, Real Time | Late Stage Venture | 10M | United States, Missouri, City of Saint Louis |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.